| Stephanie M Moses, APRN-CNP, AGACNP-BC | |
|
1401 Dr R Alexander Dr., Okmulgee, OK 74447 | |
| (918) 756-4233 | |
| Not Available |
| Full Name | Stephanie M Moses |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 10 Years |
| Location | 1401 Dr R Alexander Dr., Okmulgee, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134796774 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 200390 (Oklahoma) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 200390 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St John Physicians Inc | 2567366495 | 223 |
News Archive
A study undertaken by biologists at the University of California, Berkeley, has found that damage to a cell's DNA sets off a chain reaction that leads to the increased expression of a marker recognized by the body's immune system.
A recent study in Health Services Research based on 15 years of hospital data suggests that cuts in Medicare prices under the Affordable Care Act may slow the growth in total overall hospital spending.
Early research suggests that patients with periocular basal cell carcinoma may benefit from treatment with a drug targeting the Hedgehog signaling pathway.
The study by Paromita Hore, PhD, MPH, and colleagues at the NYC Department of Health and Mental Hygiene highlights the potential risks of lead exposure from "non-traditional" sources, even as US population blood levels continue to decline.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
› Verified 6 days ago
| Entity Name | St John Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336194406 PECOS PAC ID: 2567366495 Enrollment ID: O20031121000867 |
News Archive
A study undertaken by biologists at the University of California, Berkeley, has found that damage to a cell's DNA sets off a chain reaction that leads to the increased expression of a marker recognized by the body's immune system.
A recent study in Health Services Research based on 15 years of hospital data suggests that cuts in Medicare prices under the Affordable Care Act may slow the growth in total overall hospital spending.
Early research suggests that patients with periocular basal cell carcinoma may benefit from treatment with a drug targeting the Hedgehog signaling pathway.
The study by Paromita Hore, PhD, MPH, and colleagues at the NYC Department of Health and Mental Hygiene highlights the potential risks of lead exposure from "non-traditional" sources, even as US population blood levels continue to decline.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
› Verified 6 days ago
| Entity Name | Creek Nation Hospital & Clinics |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366593923 PECOS PAC ID: 5698786226 Enrollment ID: O20070821000130 |
News Archive
A study undertaken by biologists at the University of California, Berkeley, has found that damage to a cell's DNA sets off a chain reaction that leads to the increased expression of a marker recognized by the body's immune system.
A recent study in Health Services Research based on 15 years of hospital data suggests that cuts in Medicare prices under the Affordable Care Act may slow the growth in total overall hospital spending.
Early research suggests that patients with periocular basal cell carcinoma may benefit from treatment with a drug targeting the Hedgehog signaling pathway.
The study by Paromita Hore, PhD, MPH, and colleagues at the NYC Department of Health and Mental Hygiene highlights the potential risks of lead exposure from "non-traditional" sources, even as US population blood levels continue to decline.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie M Moses, APRN-CNP, AGACNP-BC 1306 E 26th St, Tulsa, OK 74114-2734 Ph: (918) 230-0580 | Stephanie M Moses, APRN-CNP, AGACNP-BC 1401 Dr R Alexander Dr., Okmulgee, OK 74447 Ph: (918) 756-4233 |
News Archive
A study undertaken by biologists at the University of California, Berkeley, has found that damage to a cell's DNA sets off a chain reaction that leads to the increased expression of a marker recognized by the body's immune system.
A recent study in Health Services Research based on 15 years of hospital data suggests that cuts in Medicare prices under the Affordable Care Act may slow the growth in total overall hospital spending.
Early research suggests that patients with periocular basal cell carcinoma may benefit from treatment with a drug targeting the Hedgehog signaling pathway.
The study by Paromita Hore, PhD, MPH, and colleagues at the NYC Department of Health and Mental Hygiene highlights the potential risks of lead exposure from "non-traditional" sources, even as US population blood levels continue to decline.
SuperGen, Inc. today announced that it has enrolled the first patient in its first in human study of SGI-110, a second-generation hypomethylating agent, in patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML).
› Verified 6 days ago
Jearlyn Kay Nick, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1151 S Belmont Ave, Suite 101, Okmulgee, OK 74447 Phone: 918-759-2200 Fax: 918-759-2206 | |
Amanda Lynne Doane, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-591-5700 | |
Shawn Lynn Howell, APRN, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15495 N 247 Rd, Okmulgee, OK 74447 Phone: 918-733-1351 | |
Penni Young Garland, RNC, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1101 S Belmont Ave, Ste. 105, Okmulgee, OK 74447 Phone: 918-756-2533 Fax: 918-756-9588 | |
Teri M Garner, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-758-2717 Fax: 918-756-4490 | |
Lacy Garrison, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 S Alabama Ave, Okmulgee, OK 74447 Phone: 918-756-2800 |